278 related articles for article (PubMed ID: 36652155)
1. Oligometastatic Colorectal Cancer: A Review of Definitions and Patient Selection for Local Therapies.
Miller ED; Hitchcock KE; Romesser PB
J Gastrointest Cancer; 2023 Dec; 54(4):1116-1127. PubMed ID: 36652155
[TBL] [Abstract][Full Text] [Related]
2. Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: a pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur).
Hitchcock KE; Miller ED; Shi Q; Dixon JG; Gholami S; White SB; Wu C; Goulet CC; George M; Jee KW; Wright CL; Yaeger R; Shergill A; Hong TS; George TJ; O'Reilly EM; Meyerhardt JA; Romesser PB
BMC Cancer; 2024 Feb; 24(1):201. PubMed ID: 38350888
[TBL] [Abstract][Full Text] [Related]
3. Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-Up.
Agolli L; Bracci S; Nicosia L; Valeriani M; De Sanctis V; Osti MF
Clin Colorectal Cancer; 2017 Mar; 16(1):58-64. PubMed ID: 27522627
[TBL] [Abstract][Full Text] [Related]
4. Oligometastatic breast cancer: where are we now and where are we headed?-a narrative review.
Kent CL; McDuff SGR; Salama JK
Ann Palliat Med; 2021 May; 10(5):5954-5968. PubMed ID: 32921069
[TBL] [Abstract][Full Text] [Related]
5. [Local ablative radiotherapy of oligometastatic colorectal cancer].
Petersen C; Gauer T
Radiologe; 2017 Feb; 57(2):105-110. PubMed ID: 28054139
[TBL] [Abstract][Full Text] [Related]
6. A Contemporary Update on the Role of Stereotactic Body Radiation Therapy (SBRT) for Liver Metastases in the Evolving Landscape of Oligometastatic Disease Management.
Robin TP; Raben D; Schefter TE
Semin Radiat Oncol; 2018 Oct; 28(4):288-294. PubMed ID: 30309639
[TBL] [Abstract][Full Text] [Related]
7. An analysis of a large multi-institutional database reveals important associations between treatment parameters and clinical outcomes for stereotactic body radiotherapy (SBRT) of oligometastatic colorectal cancer.
Sheikh S; Chen H; Sahgal A; Poon I; Erler D; Badellino S; Dagan R; Foote MC; Louie AV; Redmond KJ; Ricardi U; Biswas T
Radiother Oncol; 2022 Feb; 167():187-194. PubMed ID: 34952002
[TBL] [Abstract][Full Text] [Related]
8. Treatment Strategies for Oligometastatic Breast Cancer.
Nesbit EG; Donnelly ED; Strauss JB
Curr Treat Options Oncol; 2021 Aug; 22(10):94. PubMed ID: 34426881
[TBL] [Abstract][Full Text] [Related]
9. Alliance for Clinical Trials in Oncology (Alliance) trial A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur).
Hitchcock KE; Miller ED; Shi Q; Dixon JG; Gholami S; White SB; Wu C; Goulet CC; George M; Jee KW; Wright CL; Yaeger R; Shergill A; Hong TS; George TJ; O'Reilly EM; Meyerhardt JA; Romesser PB
Res Sq; 2023 Dec; ():. PubMed ID: 38196590
[TBL] [Abstract][Full Text] [Related]
10. The management of oligometastatic disease in colorectal cancer: Present strategies and future perspectives.
Carconi C; Cerreti M; Roberto M; Arrivi G; D'Ambrosio G; De Felice F; Di Civita MA; Iafrate F; Lucatelli P; Magliocca FM; Picchetto A; Picone V; Catalano C; Cortesi E; Tombolini V; Mazzuca F; Tomao S
Crit Rev Oncol Hematol; 2023 Jun; 186():103990. PubMed ID: 37061075
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic body radiation therapy for colorectal liver metastases.
Mohamad I; Barry A; Dawson L; Hosni A
Int J Hyperthermia; 2022; 39(1):611-619. PubMed ID: 35465818
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiation therapy for metastatic lung metastases.
Kimura T; Fujiwara T; Kameoka T; Adachi Y; Kariya S
Jpn J Radiol; 2022 Oct; 40(10):995-1005. PubMed ID: 36097233
[TBL] [Abstract][Full Text] [Related]
13. Radiosensitivity of Colon and Rectal Lung Oligometastasis Treated With Stereotactic Ablative Radiotherapy.
Kinj R; Bondiau PY; François E; Gérard JP; Naghavi AO; Leysalle A; Chamorey E; Evesque L; Padovani B; Ianessi A; Benezery K; Doyen J
Clin Colorectal Cancer; 2017 Sep; 16(3):e211-e220. PubMed ID: 27670890
[TBL] [Abstract][Full Text] [Related]
14. Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer.
Takeda A; Sanuki N; Kunieda E
World J Gastroenterol; 2014 Apr; 20(15):4220-9. PubMed ID: 24764660
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors for survival of oligometastatic colorectal cancer treated with Stereotactic body radiation therapy.
Franzese C; Comito T; Toska E; Tozzi A; Clerici E; De Rose F; Franceschini D; Navarria P; Reggiori G; Tomatis S; Scorsetti M
Radiother Oncol; 2019 Apr; 133():220-226. PubMed ID: 30414754
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic body radiotherapy for oligo-recurrence within the nodal area from colorectal cancer.
Seo YS; Kim MS; Yoo HJ; Jang WI
World J Gastroenterol; 2014 Feb; 20(8):2005-13. PubMed ID: 24587675
[TBL] [Abstract][Full Text] [Related]
17. Metastasis-Directed Local Therapy of Hepatic Oligometastasis from Colorectal Cancer and Future Perspective in Radiation Therapy.
Yoo GS; Rim CH; Cho WK; Jeong JU; Chie EK; Cho HM; Um JW; Ahn YC; Lee JH;
Cancer Res Treat; 2023 Jul; 55(3):707-719. PubMed ID: 36960629
[TBL] [Abstract][Full Text] [Related]
18. Ablative dose stereotactic body radiation therapy for oligometastatic disease: a prospective single institution study.
Burkon P; Kazda T; Pospisil P; Slavik M; Kominek L; Selingerova I; Blakaj DM; Prochazka T; Vrzal M; Rehak Z; Slampa P
Neoplasma; 2019 Mar; 66(2):315-325. PubMed ID: 30509112
[TBL] [Abstract][Full Text] [Related]
19. A matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage non-small cell lung cancer.
Wang X; Zamdborg L; Ye H; Grills IS; Yan D
BMC Cancer; 2018 Oct; 18(1):962. PubMed ID: 30305131
[TBL] [Abstract][Full Text] [Related]
20. Oligometastases: history of a hypothesis.
Milano MT; Biswas T; Simone CB; Lo SS
Ann Palliat Med; 2021 May; 10(5):5923-5930. PubMed ID: 32279519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
